The present invention relates to substituted diphenyl heterocycle
compounds having an oxadiazole moiety and pharmaceutical compositions
thereof that inhibit replication of HCV virus. The present invention also
relates to the use of the compounds and/or compositions to inhibit HCV
replication and/or proliferation and to treat or prevent HCV infections.